The significant elevation of fecal lactoferrin levels in IBD patients, as compared to those with IBS and healthy individuals, highlights its potential as a non-invasive, cost-effective diagnostic tool for IBD. The gene discussed is LTF; the disease is irritable bowel syndrome.